First National Bank of Mount Dora Trust Investment Services boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 177.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,260 shares of the company's stock after purchasing an additional 4,644 shares during the period. First National Bank of Mount Dora Trust Investment Services' holdings in HCA Healthcare were worth $3,436,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Sumitomo Life Insurance Co. increased its position in HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company's stock worth $946,000 after purchasing an additional 20 shares in the last quarter. MJP Associates Inc. ADV lifted its stake in shares of HCA Healthcare by 2.9% in the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company's stock valued at $350,000 after acquiring an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC increased its holdings in HCA Healthcare by 7.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company's stock worth $140,000 after purchasing an additional 21 shares in the last quarter. Anchyra Partners LLC boosted its stake in shares of HCA Healthcare by 3.7% during the first quarter. Anchyra Partners LLC now owns 587 shares of the company's stock valued at $278,000 after purchasing an additional 21 shares in the last quarter. Finally, Plato Investment Management Ltd boosted its position in HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company's stock worth $1,833,000 after buying an additional 22 shares during the period. Institutional investors own 62.73% of the company's stock.
Analyst Ratings Changes
Several analysts recently weighed in on the stock. TD Cowen reduced their price objective on shares of HCA Healthcare from $500.00 to $431.00 and set a "buy" rating on the stock in a research note on Monday, June 22nd. Royal Bank Of Canada restated an "outperform" rating and set a $435.00 price objective on shares of HCA Healthcare in a research report on Monday, July 27th. Weiss Ratings downgraded shares of HCA Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Tuesday, June 9th. UBS Group dropped their price target on shares of HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a research report on Monday, July 27th. Finally, Leerink Partners dropped their target price on shares of HCA Healthcare from $573.00 to $500.00 and set an "outperform" rating on the stock in a report on Monday, April 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $465.05.
View Our Latest Research Report on HCA Healthcare
HCA Healthcare Trading Up 0.2%
Shares of NYSE HCA opened at $403.44 on Monday. The firm's 50-day moving average price is $387.06 and its 200-day moving average price is $450.99. The firm has a market capitalization of $87.35 billion, a P/E ratio of 13.51, a P/E/G ratio of 1.40 and a beta of 1.10. HCA Healthcare, Inc. has a 1-year low of $353.13 and a 1-year high of $556.52.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. During the same period in the previous year, the company posted $6.84 EPS. The firm's revenue was up 8.7% compared to the same quarter last year. Equities research analysts forecast that HCA Healthcare, Inc. will post 29.45 EPS for the current year.
HCA Healthcare Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is currently 10.45%.
About HCA Healthcare
(
Free Report)
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.